A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence

NCT01739192 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Cocaine Use Disorders

Interventions

DRUG: Bupropion

Sponsor

Craig Rush

Collaborators

[object Object]